Sort
34,240 grants matching “atherosclerosis”
Pathological flow-induced endothelial damage and plaque erosion
$788,251Jun-Ichi Abe · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · HL
HDL Proteins and Coronary Heart Disease
$788,196Frank M Sacks · Harvard School Of Public Health · R01 · FY2017 · HL
A Randomized Controlled Trial of Gamification and Social Incentives to Increase Adherence to Physical Activity Among Patients with Heart Failure with Preserved Ejection Fraction
$788,143Alexander Craig Fanaroff · University Of Pennsylvania · R01 · FY2025 · HL
Integrated epidemiology of systemic and plaque-specific immunologic features of human atherosclerosis
$788,083Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2025 · HL
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
$788,049Alexander P Reiner · Fred Hutchinson Cancer Research Center · R01 · FY2016 · HL
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)
$787,916University Of Texas Hlth Sci Ctr San Ant · U01 · FY2004 · DK
Biogenesis of the endoplasmic reticulum
$787,865William Prinz · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Intracoronary imaging of plaque collagen in patients
$787,767Seemantini K Nadkarni · Massachusetts General Hospital · R01 · FY2016 · HL
TOPMed Omics of Cardiovascular Disease in Diabetes
$787,730James B Meigs · Massachusetts General Hospital · R01 · FY2023 · HL
Mitochondrial DNA Copy Number and Genetic Variation in Coronary Heart Disease
$787,689Dan E Arking · Johns Hopkins University · R01 · FY2018 · HL
Epigenetic Reprogramming in HIV-Associated Cardio-Vascular Disease
$787,681Michael Ilya Bukrinsky · George Washington University · R01 · FY2018 · HL
Role of Glycine Metabolism in Cardiovascular Disease
$787,639Hooman Allayee · University Of Southern California · R01 · FY2018 · HL
Role of Glycine Metabolism in Cardiovascular Disease
$787,639Hooman Allayee · University Of Southern California · R01 · FY2020 · HL
Role of Glycine Metabolism in Cardiovascular Disease
$787,639Hooman Allayee · University Of Southern California · R01 · FY2019 · HL
Early myocardial remodeling and progressive kidney function decline in type 1 diabetes
$787,613Alessandro Doria · Joslin Diabetes Center · R01 · FY2023 · HL
Framingham: Inflammation, Genes & Cardiovascular Disease
$787,498Emelia J. Benjamin · Boston University Medical Campus · R01 · FY2007 · HL
Mental Stress and Myocardial Ischemia after MI: Sex Differences and Mechanisms
$787,460Viola Vaccarino Vaccarino · Emory University · R01 · FY2014 · HL
BIOBEHAVIORAL FACTORS IN ATHEROSCLEROTIC PROGRESSION
$787,454University Of Pittsburgh At Pittsburgh · R01 · FY2002 · HL
A New-Generation Lipid-Lowering and Anti-Inflammatory siRNA Therapy for Atherosclerosis
$787,453Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2025 · HL
The Risk of Myocardial Infarction in Patients with Psoriasis
$787,421Joel M Gelfand · University Of Pennsylvania · R01 · FY2009 · HL
Improving Lipid Management Strategies in Young Adults
$787,387Yiyi Zhang · Columbia University Health Sciences · R01 · FY2023 · HL
Dietary Etiologies of Heart Disease
$787,348Eric B Rimm · Harvard School Of Public Health · R01 · FY2021 · HL
Systems Biology of Angiogenesis in Peripheral Arterial Disease
$787,287Aleksander S. Popel · Johns Hopkins University · R01 · FY2018 · HL
Sterol regulation of immunometabolic responses in cardiometabolic diseases
$787,267Carlos Fernandez Hernando · Yale University · R01 · FY2025 · HL
The genetics of functional decline in the aging vestibular system: A GWAS and gene expression analysis in aging mice and humans
$787,265Rick A. Friedman · University Of California, San Diego · R01 · FY2025 · DC